The role of blood glucose-lowering drugs in the light of the UKPDS. United Kingdom Prospective Diabetes Study.
Monnier
L
L
Service Maladies Métaboliques, H pital Lapeyronie, Montpellier, France.
D000465:Algorithms; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D006943:Hyperglycemia / Q000209:etiology; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007328:Insulin / Q000378:metabolism; D007333:Insulin Resistance; D000078790:Insulin Secretion; D019518:Postprandial Period; D011446:Prospective Studies; D006113:United Kingdom
D007004:Hypoglycemic Agents; D007328:Insulin